The development of novel mouse monoclonal antibodies against the CC531 rat colon adenocarcinoma

[1]  A. Vahrmeijer,et al.  Development of resistance to glutathione depletion-induced cell death in CC531 colon carcinoma cells: association with increased expression of bcl-2. , 2000, Biochemical pharmacology.

[2]  G. Fleuren,et al.  Bispecific antibodies in cancer therapy, from the laboratory to the clinic. , 1999, Journal of immunotherapy.

[3]  A. Heriot,et al.  Adjuvant therapy for resectable rectal and colonic cancer , 1998, The British journal of surgery.

[4]  L. Stocchi,et al.  Diagnostic and therapeutic applications of monoclonal antibodies in colorectal cancer , 1998, Diseases of the colon and rectum.

[5]  G. Fleuren,et al.  Regional administration of natural killer cells in a rat hepatic metastasis model results in better tumor infiltration and anti‐tumor response than systemic administration , 1998, International journal of cancer.

[6]  G. Fleuren,et al.  Characterization of three new membrane structures on rat NK cells which are involved in activation of the lytic machinery. , 1997, Immunobiology.

[7]  Susanne M. Smorenburg,et al.  Three‐dimensional reconstruction of colon carcinoma metastases in liver , 1997, Journal of microscopy.

[8]  G. Fleuren,et al.  The role of MHC class I expression in rat NK cell-mediated lysis of syngeneic tumor cells and virus-infected cells. , 1996, Immunobiology.

[9]  G. Riethmüller,et al.  Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma , 1994, The Lancet.

[10]  G. Fleuren,et al.  The infiltration of experimentally induced lung metastases of colon carcinoma CC531 by adoptively transferred interleukin‐2‐activated natural killer cells in wag rats , 1994, International journal of cancer.

[11]  G. Fleuren,et al.  Rat interleukin‐2‐activated natural killer (A‐NK) cell‐mediated lysis is determined by the presence of CD18 on A‐NK cells and the absence of major histocompatibility complex class I on target cells , 1994, European journal of immunology.

[12]  C. V. D. van de Velde,et al.  T‐Cell Retargeting Using Bispecific Monoclonal Antibodies in a Rat Colon Carcinoma Model: IV. Tumor Neutralization in Winn Type Assays , 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

[13]  P. Kuppen,et al.  Liver metastasis model of colon cancer in the rat: immunohistochemical characterization. , 1993, Invasion & metastasis.

[14]  G. Fleuren,et al.  T-cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model. I. Significant bispecific lysis of syngeneic colon carcinoma CC531 is critically dependent on prolonged preactivation of effector T-lymphocytes by immobilized anti-T-cell receptor antibody. , 1992, Journal of immunotherapy : official journal of the Society for Biological Therapy.

[15]  P. Kuppen,et al.  Increasing the effective concentration of melphalan in experimental rat liver tumours: comparison of isolated liver perfusion and hepatic artery infusion. , 1991, British Journal of Cancer.

[16]  J. Jeekel,et al.  Interferon treatment of a transplantable rat colon adenocarcinoma: Importance of tumor site , 1984, International journal of cancer.